Melanotransferrin: A “Missing Link” And A Novel Pharmacological Target For Treatment
Funder
National Health and Medical Research Council
Funding Amount
$613,848.00
Summary
Despite >30 years of research, the precise function of the protein, melanotransferrin (MTf), is unknown. However, we have breakthrough evidence that MTf stimulates WNT signalling as a major driver in cancer progression. We will investigate this hypothesis, which will underpin new cancer therapies. Indeed, we designed a new class of drugs that target the WNT pathway via up-regulating the WNT inhibitor, NDRG1. This drug (DpC) inhibits MTf expression to block tumour cell growth and metastasis.
Heparin-induced Thrombocytopenia And Thrombosis: Better Understanding Of Pathogenesis And Improving Diagnosis And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$653,137.00
Summary
Heparin, a widely used drug, can cause an adverse effect which results in a fall of the platelet count and the development of serious thrombosis. This drug complication is mediated by an immune mechanism. This proposal aims to provide a better understanding of the disease mechanism. It also aims to develop a new test that will improve the diagnosis, and to produce a novel drug that will effectively suppress the immune reaction and improve the treatment.
Griseofulvin, A Novel Host-directed Antimalarial Drug
Funder
National Health and Medical Research Council
Funding Amount
$461,551.00
Summary
This grant is for a Phase II clinical trial to test an FDA & TGA approved drug for a new use as an antimalarial drug. The parasite uses an enzyme from the human RBC to help it replicate & early trials show this drug appears to disrupt the life cycle of the parasite. This Phase II clinical trial will test the drug on human subjects, & if successful, the drug will be a new and novel way in which to treat and prevent malarial infections in humans.
Assessing risk of oligomictic conditions in sub-tropical water supply lakes. Assessing risk of oligomictic conditions in sub-tropical water supply lakes. This project aims to assess the risk of low rates of mixing in sub-tropical drinking water supply reservoirs, using environmental monitoring and numerical modelling. Emerging evidence suggests sub-tropical drinking water supply reservoirs could transition to low mixing states with increasing age and projected changes in global climate. While th ....Assessing risk of oligomictic conditions in sub-tropical water supply lakes. Assessing risk of oligomictic conditions in sub-tropical water supply lakes. This project aims to assess the risk of low rates of mixing in sub-tropical drinking water supply reservoirs, using environmental monitoring and numerical modelling. Emerging evidence suggests sub-tropical drinking water supply reservoirs could transition to low mixing states with increasing age and projected changes in global climate. While this risk is poorly understood, it could significantly affect the long-term reliability of water supply and potable water treatment costs. Addressing this knowledge gap is expected to develop effective management responses to ensure the long term sustainable use of these water resources.Read moreRead less
Regulating Autologous Stem Cell Therapies in Australia. This project aims to develop an ethical and regulatory framework for the use of autologous adult stem cell therapies in Australia. These therapies are increasingly being offered to patients for diseases and conditions that lack scientific evidence of safety and efficacy. This study aims to address this problem using a mixed methods approach to generate empirical data and theoretical, ethical and legal insights that will guide the responsibl ....Regulating Autologous Stem Cell Therapies in Australia. This project aims to develop an ethical and regulatory framework for the use of autologous adult stem cell therapies in Australia. These therapies are increasingly being offered to patients for diseases and conditions that lack scientific evidence of safety and efficacy. This study aims to address this problem using a mixed methods approach to generate empirical data and theoretical, ethical and legal insights that will guide the responsible development, translation and regulation of innovative stem cell therapies in Australia and internationally. Anticipated outcomes will improve patient advocacy and public knowledge about adult stem cell therapies, and facilitate better relationships between patients, researchers and clinicians.Read moreRead less
Developing a national rural volunteering roadmap. This project aims to investigate the challenges affecting rural volunteering in Australia. Conducting a national analysis of volunteering demand and supply, this project expects to generate new interdisciplinary knowledge of the structural, demographic, organisational and personal factors affecting the sustainability of rural volunteering. Expected outcomes of this project include a world-first index of volunteering vulnerabilities and a spatial ....Developing a national rural volunteering roadmap. This project aims to investigate the challenges affecting rural volunteering in Australia. Conducting a national analysis of volunteering demand and supply, this project expects to generate new interdisciplinary knowledge of the structural, demographic, organisational and personal factors affecting the sustainability of rural volunteering. Expected outcomes of this project include a world-first index of volunteering vulnerabilities and a spatial map of volunteering unevenness, leading to the development of an evidence-based National Rural Volunteering Roadmap (2025-2035), which will guide our volunteering peak body partners, governments and rural communities to plan for and support rural volunteering over the longer-term.Read moreRead less
Roles Of Impaired Apoptosis And Differentiation In Tumourigenesis And Therapy
Funder
National Health and Medical Research Council
Funding Amount
$21,656,910.00
Summary
The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remark ....The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remarkable cell suicide process termed apoptosis. Unfortunately, however, occasionally a random accident to the genes in one of our cells prevents the machinery for apoptosis from being turned on. In that case, the cell will not die when it should and, by continually dividing, it may eventually give rise to a cancer. Since most cancer cells still retain most of the machinery for apoptosis, however, a drug that could switch on this natural cell death machinery would provide a promising new approach to cancer therapy. Identifying and developing such drugs is one major long-term goal of this program. The other focus of our program concerns stem cells. These are rare cells with the remarkable ability to generate an entire tissue. For example, one of our laboratories has identified stem cells that can generate all the cells in the breast. The almost unlimited regenerative capacity of stem cells has a built-in danger. If a stem cell acquires the ability to proliferate excessively, it can go on to form a tumour. Indeed, many cancer researchers now suspect that rare stem cells within a tumour cause its inexorable growth. If tumour growth is maintained by stem cells, it will be essential to develop new forms of therapy that target these rare cancer stem cells rather than merely the bulk of the tumour cells. This is another key long-term goal of our program.Read moreRead less
Targeting An Ion Pump In The Malaria Parasite With Multiple Compound Classes
Funder
National Health and Medical Research Council
Funding Amount
$384,686.00
Summary
Large-scale antimalarial drug screening projects have identified three different classes of compound that kill the malaria parasite at extremely low doses and which hold real promise as next-generation antimalarials. Genetic evidence, as well as preliminary data from our own lab, has led us to the hypothesis that all three compound classes exert their antimalarial effect by blocking a molecular ion pump on the parasite surface. The aim of this study is to test this.
Seeing the good from the trees: remotely sensing the urban forest. Urban forests provide a range of ecosystem services including temperature regulation and rainfall capture, but measuring these benefits is currently prohibitively costly and inaccurate. This project aims to develop a new model of urban forest ecosystem services that uses remotely sensed three dimensional data to map canopy cover. A model using this data, which is being collected by an increasing number of governments, represents ....Seeing the good from the trees: remotely sensing the urban forest. Urban forests provide a range of ecosystem services including temperature regulation and rainfall capture, but measuring these benefits is currently prohibitively costly and inaccurate. This project aims to develop a new model of urban forest ecosystem services that uses remotely sensed three dimensional data to map canopy cover. A model using this data, which is being collected by an increasing number of governments, represents a novel advance on the established methodology that requires expensive and time-consuming fieldwork. The advancements expected to be made in this project will mean that environmental planners will be able to better plan the urban forest so that cities are more liveable and resilient in the face of climate change.Read moreRead less
Apoptosis And Stem Cells In Cancer Development And Therapy
Funder
National Health and Medical Research Council
Funding Amount
$22,852,198.00
Summary
To improve cancer therapy, we are studying two cancer hallmarks: enhanced cell survival and stem cell-like behaviour. As we discovered, cell death is often blocked in cancer cells. Hence, we are attempting to develop drugs that flip the natural ‘cell death switch’. Stem cells are rare cells that generate entire tissues, as we showed for the breast. Certain cancers may be driven by ‘rogue’ stem cells. If so, eradication of these rare cells within the bulk tumour may require novel therapies.